ReviewCells2026
Engineering the Immune-Stromal Microenvironment: A Design Framework for Regenerative Biomaterials.
Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The success of regenerative biomaterials depends not simply on biocompatibility but also on their ability to direct coordinated interactions between immune and stromal compartments that ultimately determine tissue repair, integration, or fibrosis. Rather than viewing inflammation and fibrosis as independent outcomes, this review presents a design framework that links engineered material properties to sequential immune activation, stromal remodeling, and long-term tissue function. We describe how material chemistry, architecture, mechanical properties, degradation behavior, surface modification, and spatiotemporal delivery of bioactive signals shape innate immune sensing, macrophage state transitions, adaptive immune regulation, and the macrophage-fibroblast axis. We further discuss how these interconnected processes regulate extracellular matrix remodeling, vascular adaptation, and fibrotic capsule formation, emphasizing that tissue fate emerges from the coordination of immune and stromal responses rather than from modulation of any single pathway. Drawing on this evidence, we propose a four-layer conceptual framework that organizes engineered inputs, biological processes, stromal responses, and tissue-level outcomes. Rather than functioning as a predictive model, the framework is intended as an evidence-mapping and experimental-design tool that makes explicit where causal links are directly supported, where they are inferred, and where they remain untested. We identify key translational gaps-including study heterogeneity, incomplete stromal and functional assessment, limited clinical validation, and insufficient longitudinal profiling-and propose practical priorities for multiparameter stromal analysis, high-dimensional myeloid phenotyping, intermediate mechanistic models, and application-relevant functional endpoints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.